2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009

Cannabis Science Partners With FHP.TV & Kush Boys Studios to Host Its Black Tie, Red Carpet Event in Los Angeles; Coined, "Cannabis Kills Cancer," a Celebratory Fund Raiser

Cannabis Science Partners With FHP.TV & Kush Boys Studios to Host Its Black Tie, Red Carpet Event in Los Angeles; Coined, "Cannabis Kills Cancer," a Celebratory Fund Raiser

LOS ANGELES, CA--(Marketwired - Jun 16, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, partners with FHP.TV & Kush Boys Studios to host its "black tie, red carpet" event in Los Angeles. Company officials state the gala is a celebratory fund raising event, coined "Cannabis Kills Cancer."

FHP.TV & Kush Boys Studios will use its social media presence and celebrity star power to help the cause and join in on this unparalleled occasion to raise money for targeted cancer and other critical ailment treatments using cannabinoids and unprecedented drug development expansions.

Kush Boys Studios recently launched www.FHP.tv, a premiere source for the cannabis and natural lifestyle communities. Based in Los Angeles, Calif., FHP is an authentic "Friends in High Places" cultural hub that offers cutting edge media content and an international cannabis industry Sponsor Member Directory.






FHP's mission is to create a community space by curating and producing high quality content for all cannabis enthusiasts from corporate boardrooms to mom-and-pop shops, as well as individuals with an appreciation for the cannabis community.

FHP is passionate about creating the technology and finding the solutions that will enhance the perception of the cannabis industry, showcase the positive environmental impact of cannabis, and reinforce cannabis as a natural resource, while elevating the quality of life for those in the community.

"We're committed to connecting people to valuable resources and providing a great media site for viewers to search, source, and connect with businesses in our industry. Anyone can explore FHP's local or international wholesome brands, co-operatives, dispensaries, medicinal doctors, delivery services, events, and more," said FHP co-founder Drue Young.

FHP.TV is created to navigate easily for mobile and tablet platforms as well as laptops and desktops. The FHP Sponsor Member Directory provides a centralized platform for individuals and businesses to connect and engage via social and traditional media. Already established strategic marketing partners include LA's iconic club the Viper Room, Cannabis Science, Ratio Formulas, Greenwolf Collective, Smell the Truth on SFGate.com, Cannabis Minority Alliance, and the NAACP.

"We already have a solid working relationship with the Kush Boys so this should only enhance and empower our efforts billed as 'The Event of the Year.' The gala has gained some great momentum already and we haven't even booked the venue yet; I'm very excited! Again, it will highlight the need for more research and development and will focus on fund raising to benefit with the battle of killing cancer and other critical ailments. Coined, 'Cannabis Kills Cancer,' we have already received calls about sponsorships and attendance," stated Raymond C. Dabney President & CEO, Co-Founder, Cannabis Science Inc.

About Cannabis Science, Inc.

Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.

Forward-Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward- looking statements may be impacted, either positively or negatively, by various factors.

Information concerning potential factors that could affect the company is detailed from time-to-time in the company's reports filed with the Securities and Exchange Commission.